Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Chemico-Biological Interactions|August 20, 2021
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cellsElena Genova, Marianna Lucafò, Marco Pelin, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 7, 2020
Midazolam oxidation in cattle liver microsomes: The role of cytochrome P450 3AAlberto Nassi, Luigi Quintieri, Roberta Merlanti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomesLuigi Quintieri, Cristina Geroni, Marianna Fantin, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 27, 2019
Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine SulfoximineFelisa Cilurzo, Maria C Cristiano, Marta Da Pian, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 18, 2006
Fluorescent, internally quenched, peptides for exploring the pH-dependent substrate specificity of cathepsin BPaolo Ruzza, Luigi Quintieri, Alessio Osler, et al.
Drug Metabolism and Pharmacokinetics|September 30, 2010
Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitroLuigi Quintieri, Sara Bortolozzo, Stefano Stragliotto, et al.
Anticancer Research|October 30, 2016
Vanillin Analogues o-Vanillin and 2,4,6-Trihydroxybenzaldehyde Inhibit NFĸB Activation and Suppress Growth of A375 Human MelanomaAnnamária Marton, Erzsébet Kúsz, Csongor Kolozsi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2005
In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterolMaura Floreani, Guglielmina Froldi, Luigi Quintieri, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 20, 2016
Thiol-Activated Anticancer Agents: The State of the ArtDaniele Dalzoppo, Veronica Di Paolo, Laura Calderan, et al.
Journal of Medicinal Chemistry|July 16, 2009
Synthesis and preliminary in vitro biological evaluation of 4-[(4-hydroxyphenyl)sulfanyl]but-3-en-2-one, a 4-mercaptophenol derivative designed as a novel bifunctional antimelanoma agentPaolo Ruzza, Antonio Rosato, Alberto Nassi, et al.
Pageof 5